The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Doxil and PARP Inhibitator Clinical Trial

antcat
antcat CSN Member Posts: 270
edited March 2014 in Ovarian Cancer #1
Hi, has anyone actually be selected for the PARP inhibitator part of the Doxil and PARP inhibitator clinical trial. Everything I've been reading is that people have signed up for this trial but were given the Doxil. So, if anyone has had the PARP portion of the trial, anything you could share with me would be helpful.

Thanks.
Like Care

Discussion Boards